Publications by authors named "C Wandel"

Claim this Profile
A
AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial.
Jerry R Mendell, Francesco Muntoni, Craig M McDonald, Eugenio M Mercuri, Emma Ciafaloni, Christoph Wandel

Nat Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunologic investigations into transgene directed immune-mediated myositis following delandistrogene moxeparvovec gene therapy.
Rachael A Potter, Ida H Moeller, Sohrab Khan, Hélène Haegel, Andreas Hollenstein, Christoph Wandel

Sci Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical Considerations for Delandistrogene Moxeparvovec Gene Therapy in Patients With Duchenne Muscular Dystrophy.
Jerry R Mendell, Crystal Proud, Craig M Zaidman, Stefanie Mason, Eddie Darton, Christoph Wandel

Pediatr Neurol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delandistrogene Moxeparvovec Gene Therapy in Ambulatory Patients (Aged ≥4 to <8 Years) with Duchenne Muscular Dystrophy: 1-Year Interim Results from Study SRP-9001-103 (ENDEAVOR).
Craig M Zaidman, Crystal M Proud, Craig M McDonald, Kelly J Lehman, Natalie L Goedeker, Christoph Wandel

Ann Neurol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Balovaptan vs Placebo for Social Communication in Childhood Autism Spectrum Disorder: A Randomized Clinical Trial.
Eric Hollander, Suma Jacob, Roger Jou, Nora McNamara, Linmarie Sikich, Christoph Wandel

JAMA Psychiatry· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis